angiotensin ii has been researched along with Coronary Thrombosis in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lazaro, EJ; Miller, MA; Spillert, CR; Sun, S | 1 |
| Conlin, PR; Gaboury, CL; Ridker, PM; Seely, EW; Vaughan, DE; Williams, GH | 1 |
| Mehta, JL | 1 |
| Ferrario, CM; López-Farré, A | 1 |
| Levi, M; Moons, AH; Peters, RJ | 1 |
2 review(s) available for angiotensin ii and Coronary Thrombosis
| Article | Year |
|---|---|
Modulation of arterial thrombosis by angiotensin-converting enzyme inhibition and angiotensin II type 1-receptor blockade.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Coronary Thrombosis; Humans; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System | 1998 |
Tissue factor and coronary artery disease.
Topics: Acute Disease; Angioplasty, Balloon, Coronary; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Anticoagulants; Arginine; Aspirin; Coronary Artery Disease; Coronary Thrombosis; Cyclosporine; Endothelium, Vascular; Factor VIIa; Heparin, Low-Molecular-Weight; Hirudin Therapy; Humans; Hypolipidemic Agents; Leukocytes, Mononuclear; Muscle, Smooth, Vascular; Recombinant Proteins; Thrombin; Thromboplastin | 2002 |
3 other study(ies) available for angiotensin ii and Coronary Thrombosis
| Article | Year |
|---|---|
Hypertension-related coronary thrombosis: prothrombic role of angiotensin II.
Topics: Angiotensin II; Blood Coagulation; Blood Coagulation Tests; Coronary Thrombosis; Humans; Hypertension; Risk Factors | 1994 |
Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function.
Topics: Angiotensin II; Coronary Thrombosis; Dose-Response Relationship, Drug; Fibrinolysis; Humans; Hypertension; Infusions, Intravenous; Plasminogen Activator Inhibitor 1; Renin-Angiotensin System; Risk Factors; Time Factors; Tissue Plasminogen Activator | 1993 |
[Vascular diseases and thrombosis].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Coronary Thrombosis; Humans; Losartan; Risk Factors; Ventricular Fibrillation | 2000 |